Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 171-180 of 411 for multiple

Edit search filters
  1. Lenalidomide And Dexamethasone In Treating Patients With Relapsed Or Refractory Multiple Myeloma

    Rochester, MN

  2. Ixazomib Plus Pomalidomide And Dexamethasone In Treating Patients With Relapsed Or Relapsed/Refractory Multiple Myeloma

    Rochester, MN

  3. A Study To Evaluate 3 Dose Schedules Of Daratumumab In Participants With Smoldering Multiple Myeloma

    Jacksonville, FL

  4. A Safety Study Of SGN-CD352A For Patients With Relapsed/Refractory Multiple Myeloma

    Scottsdale/Phoenix, AZ

  5. BT062 In Combination With Lenalidomide Or Pomalidomide And Dexamethasone In Patients With Multiple Myeloma

    Jacksonville, FL

  6. Surgical Timing And Rehabilitation (STaR) Trial For Multiple Ligament Knee Injuries (MLKIs)

    Rochester, MN

  7. Carfilzomib And Melphalan Before Stem Cell Transplant In Treating Patients With Multiple Myeloma

    Jacksonville, FL, Rochester, MN

  8. Efficacy and Safety Studies of Frexalimab (SAR441344) in Adults With Relapsing Forms of Multiple Sclerosis

    Jacksonville, FL

  9. A Study To Evaluate Subcutaneous Daratumumab In Combination With Standard Multiple Myeloma Treatment Regimens

    Jacksonville, FL

  10. A Study Of Oral LGH447 In Patients With Relapsed And/or Refractory Multiple Myeloma

    Rochester, MN

.

Mayo Clinic Footer